3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Virus Diseases
1
Urinary Bladder Neoplasms
1
Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma in Situ
1
Adenoviridae Infections
1
Interventions
valrubicin
2
Mitomycin
2
Gemcitabine
2
enfortumab vedotin
1
durvalumab
1
advexin
1
Surveys and Questionnaires
1
Standard of Care
1
Oncolytic Virotherapy
1
Nivolumab
1
Interferons
1
Cystoscopy
1
Biopsy
1
ALT-801
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Carcinoma in Situ
×
Oncolytic Virotherapy
×
Clear all
NCT01438112
2021-04-14
BOND
CG Oncology, Inc.
Phase 2/3
Terminated
22 enrolled